NMTC Financial Statements

Balance sheet, income statement, cash flow, and dividends for Neuroone Medical Technologies Corp (NMTC).


$30.50M Market Cap.

As of 12/17/2024 5:00 PM ET (MRY) • Disclaimer

NMTC Market Cap. (MRY)


NMTC Shares Outstanding (MRY)


NMTC Assets (MRY)


Total Assets

$5.37M

Total Liabilities

$4.55M

Total Investments

$0

NMTC Income (MRY)


Revenue

$3.45M

Net Income

-$12.32M

Operating Expense

$12.97M

NMTC Cash Flow (MRY)


CF Operations

-$11.01M

CF Investing

-$120.20K

CF Financing

$7.27M

NMTC Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

NMTC Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$5,369,940 (-33.68%)

$8,097,314 (-36.85%)

$12,822,609 (61.52%)

$7,938,496 (66.78%)

Assets Current

$4,630,925 (-36.67%)

$7,312,925 (-39.94%)

$12,175,763 (66.97%)

$7,292,012 (75.50%)

Assets Non-Current

$739,015 (-5.78%)

$784,389 (21.26%)

$646,846 (0.06%)

$646,484 (6.90%)

Goodwill & Intangible Assets

$67,262 (-24.91%)

$89,577 (-19.94%)

$111,892 (-16.63%)

$134,207 (-14.26%)

Shareholders Equity

$822,013 (-86.85%)

$6,249,404 (-34.93%)

$9,604,364 (46.54%)

$6,553,901 (217.20%)

Property Plant & Equipment Net

$671,753 (-3.32%)

$694,812 (29.88%)

$534,954 (4.43%)

$512,277 (14.29%)

Cash & Equivalents

$1,460,042 (-72.57%)

$5,322,493 (-34.78%)

$8,160,329 (18.24%)

$6,901,346 (70.98%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$1,455,188 (16777.62%)

$8,622 (-88.26%)

Total Investments

$0 (0%)

$0 (0%)

$2,981,010 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$2,981,010 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,635,153 (52.61%)

$1,726,686 (145.08%)

$704,538 (616.82%)

$98,287 (0%)

Trade & Non-Trade Receivables

$176,636 (0%)

$0 (0%)

$33,237 (-31.24%)

$48,336 (0%)

Trade & Non-Trade Payables

$1,029,206 (50.23%)

$685,104 (-26.15%)

$927,662 (75.42%)

$528,829 (-30.65%)

Accumulated Retained Earnings (Deficit)

-$75,004,413 (-19.65%)

-$62,686,303 (-23.33%)

-$50,826,812 (-24.49%)

-$40,827,199 (-32.22%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$194,392 (251.62%)

$55,284 (-53.76%)

$119,556 (-41.07%)

$202,895 (-83.92%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$194,392 (251.62%)

$55,284 (-53.76%)

$119,556 (-41.07%)

$202,895 (-20.22%)

Total Liabilities

$4,547,927 (146.11%)

$1,847,910 (-42.58%)

$3,218,245 (132.43%)

$1,384,595 (-48.60%)

Liabilities Current

$2,213,220 (23.46%)

$1,792,626 (-42.15%)

$3,098,689 (162.22%)

$1,181,700 (-49.84%)

Liabilities Non-Current

$2,334,707 (4123.12%)

$55,284 (-53.76%)

$119,556 (-41.07%)

$202,895 (-39.91%)

NMTC Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$3,453,003 (1.33%)

$3,407,629 (60.73%)

$2,120,041 (772.60%)

$242,958 (-87.39%)

Cost of Revenue

$2,373,336 (58.65%)

$1,495,924 (518.24%)

$241,963 (-12.30%)

$275,895 (0%)

Selling General & Administrative Expense

$7,901,695 (14.08%)

$6,926,269 (-0.76%)

$6,979,416 (11.49%)

$6,260,266 (31.71%)

Research & Development Expense

$5,065,181 (-27.02%)

$6,940,686 (40.80%)

$4,929,427 (25.59%)

$3,925,008 (89.08%)

Operating Expenses

$12,966,876 (-6.49%)

$13,866,955 (16.44%)

$11,908,843 (16.92%)

$10,185,274 (49.15%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$3,053 (-99.96%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$12,318,110 (-3.87%)

-$11,859,491 (-18.60%)

-$9,999,613 (-0.52%)

-$9,948,168 (27.07%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$12,318,110 (-3.87%)

-$11,859,491 (-18.60%)

-$9,999,613 (-0.52%)

-$9,948,168 (27.07%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$12,318,110 (-3.87%)

-$11,859,491 (-18.60%)

-$9,999,613 (-0.52%)

-$9,948,168 (27.07%)

Weighted Average Shares

$26,762,392 (47.69%)

$18,121,108 (13.27%)

$15,998,567 (49.56%)

$10,696,799 (97.52%)

Weighted Average Shares Diluted

$26,762,392 (47.69%)

$18,121,108 (13.27%)

$15,998,567 (49.56%)

$10,696,799 (97.52%)

Earning Before Interest & Taxes (EBIT)

-$12,318,110 (-3.87%)

-$11,859,491 (-18.60%)

-$9,999,613 (-0.55%)

-$9,945,115 (-62.62%)

Gross Profit

$1,079,667 (-43.52%)

$1,911,705 (1.79%)

$1,878,078 (5802.03%)

-$32,937 (-101.71%)

Operating Income

-$11,887,209 (0.57%)

-$11,955,250 (-19.19%)

-$10,030,765 (1.83%)

-$10,218,211 (-108.44%)

NMTC Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$120,197 (-104.54%)

$2,649,964 (181.67%)

-$3,244,765 (-4737.23%)

-$67,079 (45.21%)

Net Cash Flow from Financing

$7,269,586 (-1.75%)

$7,399,074 (-38.46%)

$12,023,282 (4.23%)

$11,534,854 (57.51%)

Net Cash Flow from Operations

-$11,011,840 (14.55%)

-$12,886,874 (-71.38%)

-$7,519,534 (12.59%)

-$8,602,826 (-151.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,862,451 (-36.11%)

-$2,837,836 (-325.41%)

$1,258,983 (-56.06%)

$2,864,949 (-24.12%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$3,026,581 (201.92%)

-$2,969,539 (0%)

$0 (0%)

Capital Expenditure

-$120,197 (68.09%)

-$376,617 (-36.84%)

-$275,226 (-310.30%)

-$67,079 (45.21%)

Issuance (Repayment) of Debt Securities

-$75,000 (0%)

$0 (0%)

$0 (0%)

-$3,053 (-100.04%)

Issuance (Purchase) of Equity Shares

$7,344,586 (-0.74%)

$7,399,074 (-38.46%)

$12,023,282 (6.29%)

$11,312,066 (2780.74%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,344,476 (21.62%)

$1,105,457 (16.71%)

$947,212 (-47.18%)

$1,793,199 (-2.33%)

Depreciation Amortization & Accretion

$360,325 (16.57%)

$309,098 (36.64%)

$226,213 (53.75%)

$147,130 (108.54%)

NMTC Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

31.30% (-44.21%)

56.10% (-36.68%)

88.60% (751.47%)

-13.60% (-113.60%)

Profit Margin

-356.70% (-2.50%)

-348.00% (26.22%)

-471.70% (88.48%)

-4094.60% (-478.33%)

EBITDA Margin

-346.30% (-2.15%)

-339.00% (26.46%)

-461.00% (88.57%)

-4032.80% (-1185.15%)

Return on Average Equity (ROAE)

-407.00% (-104.83%)

-198.70% (-145.01%)

-81.10% (43.60%)

-143.80% (-130.73%)

Return on Average Assets (ROAA)

-229.20% (-48.45%)

-154.40% (-114.74%)

-71.90% (32.11%)

-105.90% (74.24%)

Return on Sales (ROS)

-356.70% (-2.50%)

-348.00% (26.22%)

-471.70% (88.48%)

-4093.30% (-1189.63%)

Return on Invested Capital (ROIC)

-746.70% (-20.38%)

-620.30% (59.78%)

-1542.20% (-110.76%)

14327.10% (1506.00%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.15 (-57.08%)

-1.37 (48.94%)

-2.68 (36.83%)

-4.25 (-177.58%)

Price to Sales Ratio (P/S)

7.67 (62.05%)

4.74 (-62.87%)

12.75 (-92.67%)

173.91 (1504.91%)

Price to Book Ratio (P/B)

37.11 (988.88%)

3.41 (19.50%)

2.85 (-60.57%)

7.23 (-47.26%)

Debt to Equity Ratio (D/E)

5.53 (1769.26%)

0.3 (-11.64%)

0.34 (58.77%)

0.21 (-83.82%)

Earnings Per Share (EPS)

-0.46 (29.23%)

-0.65 (-3.17%)

-0.63 (32.26%)

-0.93 (63.10%)

Sales Per Share (SPS)

0.13 (-31.38%)

0.19 (41.35%)

0.13 (478.26%)

0.02 (-93.54%)

Free Cash Flow Per Share (FCFPS)

-0.42 (43.17%)

-0.73 (-50.31%)

-0.49 (39.95%)

-0.81 (-23.82%)

Book Value Per Share (BVPS)

0.03 (-91.01%)

0.34 (-42.50%)

0.6 (-2.12%)

0.61 (60.47%)

Tangible Assets Book Value Per Share (TABVPS)

0.2 (-55.20%)

0.44 (-44.33%)

0.79 (8.77%)

0.73 (-14.12%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0.00%)

-2 (0.00%)

-2 (50.00%)

-4 (20.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.43 (-53.50%)

-1.58 (10.75%)

-1.78 (54.94%)

-3.94 (24.40%)

Asset Turnover

0.64 (44.59%)

0.44 (192.11%)

0.15 (484.62%)

0.03 (-95.52%)

Current Ratio

2.09 (-48.71%)

4.08 (3.82%)

3.93 (-36.33%)

6.17 (249.83%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$11,132,037 (16.07%)

-$13,263,491 (-70.16%)

-$7,794,760 (10.09%)

-$8,669,905 (-144.38%)

Enterprise Value (EV)

$29,093,694 (58.95%)

$18,303,101 (5.47%)

$17,353,328 (-55.06%)

$38,618,536 (22.56%)

Earnings Before Tax (EBT)

-$12,318,110 (-3.87%)

-$11,859,491 (-18.60%)

-$9,999,613 (-0.52%)

-$9,948,168 (27.07%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$11,957,785 (-3.53%)

-$11,550,393 (-18.18%)

-$9,773,400 (0.25%)

-$9,797,985 (-62.08%)

Invested Capital

$1,823,808 (92.40%)

$947,902 (-39.67%)

$1,571,255 (2171.20%)

-$75,862 (85.62%)

Working Capital

$2,417,705 (-56.20%)

$5,520,299 (-39.18%)

$9,077,074 (48.55%)

$6,110,312 (239.64%)

Tangible Asset Value

$5,302,678 (-33.78%)

$8,007,737 (-37.00%)

$12,710,717 (62.87%)

$7,804,289 (69.54%)

Market Capitalization

$30,503,761 (43.23%)

$21,297,641 (-22.25%)

$27,393,602 (-42.21%)

$47,402,311 (67.28%)

Average Equity

$3,026,585 (-49.29%)

$5,968,826 (-51.56%)

$12,323,221 (78.10%)

$6,919,243 (337.41%)

Average Assets

$5,374,954 (-30.02%)

$7,680,191 (-44.81%)

$13,916,384 (48.14%)

$9,394,326 (183.17%)

Invested Capital Average

$1,649,761 (-13.71%)

$1,911,904 (194.86%)

$648,403 (1034.11%)

-$69,414 (89.87%)

Shares

30,811,880 (28.82%)

23,919,184 (47.57%)

16,209,232 (35.07%)

12,000,585 (63.26%)